Akorn, Inc. (AKN) Reports First Quarter 2013 Financial Results
5/7/2013 8:23:45 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013.
Raj Rai, Chief Executive Officer, commented, "We are pleased with our first quarter results although we were behind in the launches of certain products that were approved late last year due to capacity constraints with our contract manufacturing partners as well as market challenges.
Help employers find you! Check out all the jobs and post your resume.
comments powered by